Summary
The U.S. has announced a 100% tariff on patented medicines entering the country. Companies can avoid these tariffs by making deals with the government, which include starting new manufacturing in the U.S. or agreeing to specific pricing terms. The aim is to encourage drug manufacturing in the U.S. to reduce national security risks.
Key Facts
- The U.S. plans to impose a 100% tariff on patented medicines imported into the country.
- Companies can avoid the 100% tariff if they strike deals with the U.S. government.
- Companies that begin new manufacturing operations in the U.S. will only face a 20% tariff.
- If companies reach specific pricing deals with the government, the tariff could drop to zero.
- The tariffs do not apply to generic medicines.
- Many large pharmaceutical companies have already made deals to avoid the tariffs.
- Smaller and medium-sized companies have 180 days to make agreements, while larger ones have 120 days.
- The White House goal is to increase U.S. manufacturing of key medicines to reduce security risks.
